Feb 28 (Reuters) - Amarin Corporation PLC AMRN.O :
- AMARIN AND CSL SEQIRUS ANNOUNCE EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT TO COMMERCIALIZE VAZKEPA (ICOSAPENT ETHYL) IN AUSTRALIA AND NEW ZEALAND
- UNDER TERMS OF AGREEMENT, CSL SEQIRUS WILL IN-LICENSE VAZKEPA FROM AMARIN
- CSL SEQIRUS TO BE RESPONSIBLE FOR MARKET ACCESS, REIMBURSEMENT EFFORTS, DISTRIBUTION, FOR VAZKEPA ACROSS AUSTRALIA, NEW ZEALAND
- AMARIN WILL RECEIVE AN UPFRONT PAYMENT AND BE ELIGIBLE FOR EVENT-RELATED MILESTONE PAYMENTS OF UP TO APPROXIMATELY $8 MILLION
- AMARIN WILL RECEIVE ADDITIONAL PRODUCT-RELATED MILESTONE PAYMENTS OF UP TO APPROXIMATELY $4 MILLION
News: CSL Amarin And Csl Seqirus Announce Exclusive License And Distribution Agreement To...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$263.15 |
Change
-0.800(0.30%) |
Mkt cap ! $127.8B | |||
| Open | High | Low | Value | Volume |
| $264.45 | $264.45 | $259.33 | $26.75M | 102.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13 | $263.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $263.25 | 14 | 1 |
View Market Depth
| Last trade - 10.32am 23/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |